The DOI matches its Crossref record; 114 of the 114 references it cites were found in a registry or an index.
PROSTAGLANDINS AND CANCER
Open accessAbstract
Chemoprevention has been considered as a possible approach for cancer prevention. A significant effort has been made in the development of novel drugs for both cancer prevention and treatment over the past decade. Recent epidemiological studies and clinical trials indicate that long term use of aspirin and similar agents, also called non-steroidal anti-inflammatory drugs (NSAIDs), can decrease the incidence of certain malignancies, including colorectal, oesophageal, breast, lung, and bladder cancers. The best known targets of NSAIDs are cyclooxygenase (COX) enzymes, which convert arachidonic acid to prostaglandins (PGs) and thromboxane. COX-2 derived prostaglandin E(2)(PGE(2)) can promote tumour growth by binding its receptors and activating signalling pathways which control cell proliferation, migration, apoptosis, and/or angiogenesis. However, the prolonged use of high dosages of COX-2 selective inhibitors (COXIBs) is associated with unacceptable cardiovascular side effects. Thus it is crucial to develop more effective chemopreventive agents with minimal toxicity. Recent efforts to identify the molecular mechanisms by which PGE(2) promotes tumour growth and metastasis may provide opportunities for the development of safer strategies for cancer prevention and treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inhibition of Prostaglandin Synthesis as a Mechanism of Action for Aspirin-like Drugs
VANE, J. R. (1971) · Nature New Biology · doi:10.1038/newbio231232a0 · Cited by 8,605
Inflammation and cancer: back to Virchow?
Balkwill, F., & Mantovani, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04046-0 · Cited by 7,746
Bombardier, C., Laine, L., Reicin, A., Shapiro, D., Burgos-Vargas, R., Davis, B., Day, R., Ferraz, M. B., Hawkey, C. J., Hochberg, M. C., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011233432103 · Cited by 4,027
Vane, J. R., Bakhle, Y. S., & Botting, R. M. (1998) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.38.1.97 · Cited by 2,734
The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor, in Familial Adenomatous Polyposis
Steinbach, G., Lynch, P. M., Phillips, R. K. S., Wallace, M. H., Hawk, E., Gordon, G. B., Wakabayashi, N., Saunders, B., Shen, Y., Fujimura, T., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006293422603 · Cited by 2,526
Cardiovascular Events Associated with Rofecoxib in a Colorectal Adenoma Chemoprevention Trial
Bresalier, R. S., Sandler, R. S., Quan, H., Bolognese, J. A., Oxenius, B., Horgan, K., Lines, C., Riddell, R., Morton, D., Lanas, A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050493 · Cited by 2,519
Cyclooxygenase in biology and disease
DuBois, R. N., Abramson, S. B., Crofford, L., Gupta, R. A., Simon, L. S., van de Putte, L. B. A., & Lipsky, P. E. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.12.1063 · Cited by 2,506
Cancer and the chemokine network
Balkwill, F. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1388 · Cited by 2,343
Cyclooxygenase regulates angiogenesis induced by colon cancer cells
Tsujii, M., Kawano, S., Tsuji, S., Sawaoka, H., Hori, M., & DuBois, R. N. (1998) · Cell · doi:10.1016/s0092-8674(00)81433-6 · Cited by 2,272
Self-citationTsujii, M., & DuBois, R. N. (1995) · Cell · doi:10.1016/0092-8674(95)90127-2 · Cited by 2,267
Cardiovascular Risk Associated with Celecoxib in a Clinical Trial for Colorectal Adenoma Prevention
Solomon, S. D., McMurray, J. J. V., Pfeffer, M. A., Wittes, J., Fowler, R., Finn, P., Anderson, W. F., Zauber, A., Hawk, E., & Bertagnolli, M. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050405 · Cited by 2,052
Gastrointestinal Toxicity of Nonsteroidal Antiinflammatory Drugs
Wolfe, M. M., Lichtenstein, D. R., & Singh, G. (1999) · New England Journal of Medicine · doi:10.1056/nejm199906173402407 · Cited by 1,956
Risk of Cardiovascular Events Associated with Selective COX-2 Inhibitors
Mukherjee, D. (2001) · JAMA · doi:10.1001/jama.286.8.954 · Cited by 1,741
Thun, M. J., Henley, S. J., & Patrono, C. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.4.252 · Cited by 1,433
Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors.
Masferrer, J. L., Leahy, K. M., Koki, A. T., Zweifel, B. S., Settle, S. L., Woerner, B. M., Edwards, D. A., Flickinger, A. G., Moore, R. J., & Seibert, K. (2000) · PubMed · Cited by 1,401
McAdam, B. F., Catella-Lawson, F., Mardini, I. A., Kapoor, S., Lawson, J. A., & FitzGerald, G. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.1.272 · Cited by 1,305
Peroxisome-Proliferator-Activated Receptor δ Activates Fat Metabolism to Prevent Obesity
Wang, Y.-X., Lee, C.-H., Tiep, S., Yu, R. T., Ham, J., Kang, H., & Evans, R. M. (2003) · Cell · doi:10.1016/s0092-8674(03)00269-1 · Cited by 1,296
Prostaglandins as modulators of immunity
Harris, S. G., Padilla, J., Koumas, L., Ray, D., & Phipps, R. P. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(01)02154-8 · Cited by 1,180
Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells.
Sheng, H., Shao, J., Morrow, J. D., Beauchamp, R. D., & Dubois, R. N. (1998) · PubMed · Cited by 1,114
Complications of the COX-2 Inhibitors Parecoxib and Valdecoxib after Cardiac Surgery
Nussmeier, N. A., Whelton, A. A., Brown, M. T., Langford, R. M., Hoeft, A., Parlow, J. L., Boyce, S. W., & Verburg, K. M. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050330 · Cited by 1,092
PPARδ Is an APC-Regulated Target of Nonsteroidal Anti-Inflammatory Drugs
He, T.-C., Chan, T. A., Vogelstein, B., & Kinzler, K. W. (1999) · Cell · doi:10.1016/s0092-8674(00)81664-5 · Cited by 1,085
Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2
Gupta, R. A., & DuBois, R. N. (2001) · Nature Reviews Cancer · doi:10.1038/35094017 · Cited by 1,066
Jakobsson, P.-J., Thorén, S., Morgenstern, R., & Samuelsson, B. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.13.7220 · Cited by 996
Role of BAX in the Apoptotic Response to Anticancer Agents
Zhang, L., Yu, J., Park, B. H., Kinzler, K. W., & Vogelstein, B. (2000) · Science · doi:10.1126/science.290.5493.989 · Cited by 863
Pai, R., Soreghan, B., Szabo, I. L., Pavelka, M., Baatar, D., & Tarnawski, A. S. (2002) · Nature Medicine · doi:10.1038/nm0302-289 · Cited by 836
Tanaka, T., Yamamoto, J., Iwasaki, S., Asaba, H., Hamura, H., Ikeda, Y., Watanabe, M., Magoori, K., Ioka, R. X., Tachibana, K., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0306981100 · Cited by 832
Neuroprotection by Aspirin and Sodium Salicylate Through Blockade of NF-κB Activation
Grilli, M., Pizzi, M., Memo, M., & Spano, P. (1996) · Science · doi:10.1126/science.274.5291.1383 · Cited by 750
Infections as a major preventable cause of human cancer
Kuper, H., Adami, H. ‐., & Trichopoulos, D. (2000) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2000.00742.x · Cited by 740
Regulation of the immune response by prostaglandins
Goodwin, J. S., & Ceuppens, J. (1983) · Journal of Clinical Immunology · doi:10.1007/bf00915791 · Cited by 715
Prostaglandin E2 Increases Growth and Motility of Colorectal Carcinoma Cells
Sheng, H., Shao, J., Washington, M. K., & DuBois, R. N. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009689200 · Cited by 653
Acceleration of intestinal polyposis through prostaglandin receptor EP2 in ApcΔ716 knockout mice
Sonoshita, M., Takaku, K., Sasaki, N., Sugimoto, Y., Ushikubi, F., Narumiya, S., Oshima, M., & Taketo, M. M. (2001) · Nature Medicine · doi:10.1038/nm0901-1048 · Cited by 587
Anderson, G. D., Hauser, S. D., McGarity, K. L., Bremer, M. E., Isakson, P. C., & Gregory, S. A. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118717 · Cited by 571
Altered eicosanoid levels in human colon cancer.
Rigas, B., Goldman, I. S., & Levine, L. (1993) · PubMed · Cited by 569
Sulindac Inhibits Activation of the NF-κB Pathway
Yamamoto, Y., Yin, M.-J., Lin, K.-M., & Gaynor, R. B. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.38.27307 · Cited by 494
Combinatorial chemoprevention of intestinal neoplasia
Torrance, C. J., Jackson, P. E., Montgomery, E., Kinzler, K. W., Vogelstein, B., Wissner, A., Nunes, M., Frost, P., & Discafani, C. M. (2000) · Nature Medicine · doi:10.1038/79534 · Cited by 493
Huang, M., Stolina, M., Sharma, S. P., Mao, J. T., Zhu, L. X., Miller, P. W., Wollman, J. S., Herschman, H. R., & Dubinett, S. M. (1998) · PubMed · Cited by 492
Laine, L., Harper, S., Simon, T., Bath, R., Johanson, J., Schwartz, H., Stern, S., Quan, H., & Bolognese, J. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70334-3 · Cited by 474
Stolina, M., Sharma, S., Lin, Y., Dohadwala, M., Gardner, B., Luo, J., Zhu, L., Kronenberg, M., Miller, P. W., Portanova, J., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.1.361 · Cited by 465
Buchanan, F. G., Wang, D., Bargiacchi, F., & DuBois, R. N. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302474200 · Cited by 463
Self-citationSelective Inhibition of Vascular Endothelial Growth Factor–Mediated Angiogenesis by Cyclosporin a
Hernández, G. L., Volpert, O. V., Íñiguez, M. A., Lorenzo, E., Martínez-Martínez, S., Grau, R., Fresno, M., & Redondo, J. M. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.5.607 · Cited by 432
Portanova, J. P., Zhang, Y., Anderson, G. D., Hauser, S. D., Masferrer, J. L., Seibert, K., Gregory, S. A., & Isakson, P. C. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.3.883 · Cited by 421
Transcription of cyclooxygenase-2 is enhanced in transformed mammary epithelial cells.
Subbaramaiah, K., TELANG, N. T., Ramonetti, J. T., Araki, R., DeVito, B., Weksler, B. B., & Dannenberg, A. J. (1996) · PubMed · Cited by 418
Silencing of CXCR4 Blocks Breast Cancer Metastasis
Liang, Z., Yoon, Y., Votaw, J., Goodman, M. M., Williams, L., & Shim, H. (2005) · Cancer Research · doi:10.1158/0008-5472.967.65.3 · Cited by 402
Adderley, S. R., & Fitzgerald, D. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.8.5038 · Cited by 371
Involvement of prostaglandin E receptor subtype EP(4) in colon carcinogenesis.
Mutoh, M., Watanabe, K., Kitamura, T., Shoji, Y., Takahashi, M., Kawamori, T., Tani, K., Kobayashi, M., Maruyama, T., Kobayashi, K., et al. (2002) · PubMed · Cited by 362
Chang, S.-H., Liu, C. H., Conway, R., Han, D. K., Nithipatikom, K., Trifan, O. C., Lane, T. F., & Hla, T. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2535911100 · Cited by 361
Colorectal Cancer and Nonsteroidal Anti-inflammatory Drugs
Smalley, W. E., & DuBois, R. N. (1997) · Advances in Pharmacology · doi:10.1016/s1054-3589(08)60067-8 · Cited by 356
Regulation of the Macrophage Content of Neoplasms by Chemoattractants
Bottazzi, B., Polentarutti, N., Acero, R., Balsari, A., Boraschi, D., Ghezzi, P., Salmona, M., & Mantovani, A. (1983) · Science · doi:10.1126/science.6828888 · Cited by 352
Role of the prostaglandin E receptor subtype EP1 in colon carcinogenesis.
Watanabe, K., Kawamori, T., Nakatsugi, S., Ohta, T., Ohuchida, S., Yamamoto, H., Maruyama, T., Kondo, K., Ushikubi, F., Narumiya, S., et al. (1999) · PubMed · Cited by 351
Rolland, P. H., Martin, P., Jacquemier, J. D., Rolland, A. M., & Toga, M. (1980) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/64.5.1061 · Cited by 348
Shreedhar, V., Giese, T., Sung, V. W., & Ullrich, S. E. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.8.3783 · Cited by 345
Wang, D., Wang, H., Shi, Q., Katkuri, S., Walhi, W., Desvergne, B., Das, S. K., Dey, S. K., & DuBois, R. N. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.08.011 · Cited by 340
Self-citationMarchesi, F., Monti, P., Leone, B. E., Zerbi, A., Vecchi, A., Piemonti, L., Mantovani, A., & Allavena, P. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1343 · Cited by 339
Prostaglandin catabolizing enzymes
Tai, H.-H., Ensor, C. M., Tong, M., Zhou, H., & Yan, F. (2002) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s0090-6980(02)00050-3 · Cited by 337
Prostaglandin E2 Suppresses Chemokine Production in Human Macrophages through the EP4 Receptor
Takayama, K., Garcı́a-Cardeña, G., Sukhova, G. K., Comander, J., Gimbrone, M. A., & Libby, P. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204810200 · Cited by 337
Host Prostaglandin E2-EP3 Signaling Regulates Tumor-Associated Angiogenesis and Tumor Growth
Amano, H., Hayashi, I., Endo, H., Kitasato, H., Yamashina, S., Maruyama, T., Kobayashi, M., Satoh, K., Narita, M., Sugimoto, Y., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021408 · Cited by 325
15-Hydroxyprostaglandin Dehydrogenase Is Down-regulated in Colorectal Cancer
Backlund, M. G., Mann, J. R., Holla, V. R., Buchanan, F. G., Tai, H.-H., Musiek, E. S., Milne, G. L., Katkuri, S., & DuBois, R. N. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411221200 · Cited by 301
Gupta, R. A., Wang, D., Katkuri, S., Wang, H., Dey, S. K., & DuBois, R. N. (2004) · Nature Medicine · doi:10.1038/nm993 · Cited by 275
Self-citationCyclooxygenase inhibitors suppress angiogenesis and reduce tumor growth in vivo.
Sawaoka, H., Tsuji, S., Tsujii, M., Gunawan, E. S., Sasaki, Y., Kawano, S., & Hori, M. (1999) · PubMed · Cited by 270
Positive and Negative Regulation of NF-κB by COX-2
Poligone, B., & Baldwin, A. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106599200 · Cited by 263
The discovery and function of COX-2.
Needleman, P., & Isakson, P. C. (1997) · PubMed · Cited by 256
Uefuji, K., Ichikura, T., & Mochizuki, H. (2000) · PubMed · Cited by 253
Ombardier, C. L. B., Aine, L. O. L., Eicin, A. L. R., Hapiro, D. E. S., Urgos, R. U. B., Avis, B. A. D., Ay, R., Arcos, M. J., Erraz, B. O. F., Awkey, C. H. J. H., et al. (2010) · Cited by 253
Yang, L., Yamagata, N., Yadav, R., Brandon, S., Courtney, R. L., Morrow, J. D., Shyr, Y., Boothby, M., Joyce, S., Carbone, D. P., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16492 · Cited by 250
Yan, M., Rerko, R. M., Platzer, P., Dawson, D., Willis, J., Tong, M., Lawrence, E., Lutterbaugh, J., Lu, S., Willson, J. K. V., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406142101 · Cited by 243
Developmental expression of functional cyclooxygenases in zebrafish
Grosser, T., Yusuff, S., Cheskis, E., Pack, M. A., & FitzGerald, G. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.112217799 · Cited by 216
Yao, M., Kargman, S., Lam, E. C., Kelly, C. R., Zheng, Y., Luk, P., Kwong, E. C., Evans, J. F., & Wolfe, M. M. (2003) · PubMed · Cited by 213
Risk of cardiovascular events associated with selective COX-2 inhibitors
Mukherjee, D., Nissen, S. E., & Topol, E. J. (2002) · ACC Current Journal Review · doi:10.1016/s1062-1458(01)00545-1 · Cited by 208
Cyclooxygenase-2: a therapeutic target in angiogenesis
Iñiguez, M. A., Rodrı́guez, A., Volpert, O. V., Fresno, M., & Redondo, J. M. (2003) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)00011-4 · Cited by 206
PGE2 Stimulates VEGF Expression in Endothelial Cells via ERK2/JNK1 Signaling Pathways
Pai, R., Szabo, I. L., Soreghan, B. A., Atay, S., Kawanaka, H., & Tarnawski, A. S. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5494 · Cited by 195
Wang, D., Buchanan, F. G., Wang, H., Dey, S. K., & DuBois, R. N. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3671 · Cited by 193
Self-citationSheng, H., Williams, C. S., Shao, J., Liang, P., DuBois, R. N., & Beauchamp, R. D. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.34.22120 · Cited by 186
The Role of Prostaglandins and Other Eicosanoids in the Gastrointestinal Tract
Wang, D., Mann, J. R., & Dubois, R. N. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.09.080 · Cited by 186
Self-citationTargeting cyclooxygenase 2 and HER-2/neu pathways inhibits colorectal carcinoma growth
Mann, M., Sheng, H., Shao, J., Williams, C. S., Dubois, R. N., Pisacane, P. I., & Sliwkowski, M. X. (2001) · Gastroenterology · doi:10.1053/gast.2001.24844 · Cited by 179
Enhancement of colon carcinogenesis by prostaglandin E2 administration
Kawamori, T. (2003) · Carcinogenesis · doi:10.1093/carcin/bgg033 · Cited by 179
Shureiqi, I. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.14.1136 · Cited by 176
Salcedo, R., Zhang, X., Young, H. A., Michael, N., Wasserman, K., Ma, W.-H., Martins-Green, M., Murphy, W. J., & Oppenheim, J. J. (2003) · Blood · doi:10.1182/blood-2002-11-3400 · Cited by 175
Nitric oxide synthase and cyclooxygenases: distribution, regulation, and intervention in arthritis
Amin, A. R., Attur, M., & Abramson, S. B. (1999) · Current Opinion in Rheumatology · doi:10.1097/00002281-199905000-00009 · Cited by 166
Induction of Cytosolic Phospholipase A2 by Oncogenic Ras in Human Non-small Cell Lung Cancer
Heasley, L. E., Thaler, S., Nicks, M., Price, B., Skorecki, K., & Nemenoff, R. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.23.14501 · Cited by 166
Ding, Y. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh277 · Cited by 159
Tortora, G., Caputo, R., Damiano, V., Melisi, D., Bianco, R., Fontanini, G., Veneziani, B. M., Placido, S. D., Bianco, A. R., & Ciardiello, F. (2003) · PubMed · Cited by 150
Hansen‐Petrik, M., McEntee, M. F., Jull, B. A., Shi, H., Zemel, M. B., & Whelan, J. (2002) · PubMed · Cited by 143
Metabolism of PGE2 by prostaglandin dehydrogenase is essential for remodeling the ductus arteriosus
Coggins, K. G., Latour, A. M., Nguyen, M., Audoly, L., Coffman, T. M., & Koller, B. H. (2002) · Nature Medicine · doi:10.1038/nm0202-91 · Cited by 129
Cyclooxygenase Regulates Angiogenesis Induced by Colon Cancer Cells
Tsujii, M., Kawano, S., Tsuji, S., Sawaoko, H., Hori, M., & DuBois, R. N. (1998) · Cell · doi:10.1016/s0092-8674(02)09420-5 · Cited by 123
Infections as a major preventable cause of human cancer
Kuper, H., Adami, H., & Trichopoulos, D. (2001) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2001.00742.x · Cited by 121
Pradono, P., Tazawa, R., Maemondo, M., Tanaka, M., Usui, K., Saijo, Y., Hagiwara, K., & Nukiwa, T. (2002) · PubMed · Cited by 118
Prostaglandin E2 inhibits production of the inflammatory chemokines CCL3 and CCL4 in dendritic cells
Jing, H., Vassiliou, E. K., & Ganea, D. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.0303116 · Cited by 114
Moran, A. E., Hunt, D. H., Javid, S. H., Redston, M. S., Carothers, A. M., & Bertagnolli, M. M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404276200 · Cited by 113
Modulation of tumor cell gene expression and phenotype by the organspecific metastatic environment
Radinsky, R. (1995) · Cancer and Metastasis Reviews · doi:10.1007/bf00690601 · Cited by 108
Davis, T. W., O’Neal, J. M., Pagel, M. D., Zweifel, B. S., Mehta, P. P., Heuvelman, D. M., & Masferrer, J. L. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-1168 · Cited by 107
Beuckmann, C. T., Fujimori, K., Urade, Y., & Hayaishi, O. (2000) · Neurochemical Research · doi:10.1023/a:1007579507804 · Cited by 106
Spinella, F., Rosanò, L., Castro, V. D., Natali, P. G., & Bagnato, A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408584200 · Cited by 106
Studies of prostaglandins and sulphasalazine in ulcerative colitis
Gould, S. R., Brash, A. R., CONOLLY, M. E., & Lennard‐Jones, J. E. (1981) · Prostaglandins and Medicine · doi:10.1016/0161-4630(81)90088-4 · Cited by 105
Non-COX-2 targets and cancer: Expanding the molecular target repertoire of chemoprevention
Kashfi, K., & Rigas, B. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.05.004 · Cited by 102
Epidermal growth factor receptor tyrosine kinase inhibitors as potential cancer chemopreventives.
Kelloff, G. J., Fay, J. R., Steele, V. E., Lubet, R., Boone, C. W., Crowell, J. A., & Sigman, C. C. (1996) · PubMed · Cited by 96
Par-4, a proapoptotic gene, is regulated by NSAIDs in human colon carcinoma cells
Zhang, Z., & DuBois, R. N. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70352-0 · Cited by 91
Bradbury, D. A., Clarke, D. L., Seedhouse, C., Corbett, L. M., Stocks, J., & Knox, A. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414530200 · Cited by 90
Cyclooxygenase-1 signaling is required for vascular tube formation during development
Cha, Y. I., Kim, S. H., Solnica‐Krezel, L., & DuBois, R. N. (2005) · Developmental Biology · doi:10.1016/j.ydbio.2005.03.014 · Cited by 78
Lazarus, M., Munday, C. J., Eguchi, N., Matsumoto, S., Killian, G. J., Kubata, B. K., & Urade, Y. (2002) · Endocrinology · doi:10.1210/en.143.6.2410 · Cited by 78
Invasive characteristics of human prostatic epithelial cells: understanding the metastatic process
Hart, C. A., Brown, M. D., Bagley, S., Sharrard, M., & Clarke, N. W. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602325 · Cited by 68
The Role of Cyclooxygenase Inhibitors in Cancer Prevention
Anderson, W. F., Umar, A., Viner, J. L., & Hawk, E. T. (2002) · Current Pharmaceutical Design · doi:10.2174/1381612023394935 · Cited by 65
Alterations in the mucosal immune system in ulcerative colitis and crohn's disease
MacDermott, R. P. (1994) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)30096-7 · Cited by 65
Husain, S. S., Szabó, I., Pai, R., et al. (2001) · Life Sciences · doi:10.1016/s0024-3205(01)01411-4 · Cited by 64
Gastrointestinal Toxicity of Nonsteroidal Antiinflammatory Drugs
Harewood, G. C. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908123410725 · Cited by 64
Holla, V. R., Wang, D., Brown, J. R., Mann, J. R., Katkuri, S., & DuBois, R. N. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407403200 · Cited by 61
Self-citationCyclooxygenase-2 inhibitor (SC-236) suppresses activator protein-1 through c-Jun NH2-terminal kinase
Wong, B. C., JIANG, X. H., Lin, M. C. M., Tu, S. P., Cui, J. T., Jiang, S. H., Wong, W. M., Yuen, M., Lam, S. K., & Kung, H. F. (2003) · Gastroenterology · doi:10.1053/j.gastro.2003.10.063 · Cited by 60
Expression Analysis and Potential Functional Role of the CXCR4 Chemokine Receptor in Bladder Cancer
Eisenhardt, A., Frey, U. H., TACK, M., Rosskopf, D., Lümmen, G., Rubben, H., & Siffert, W. (2004) · European Urology · doi:10.1016/j.eururo.2004.10.001 · Cited by 53
Trompezinski, S., Pernet, I., Schmitt, D., & Viac, J. (2001) · Inflammation Research · doi:10.1007/pl00000265 · Cited by 52
Quidville, V., Segond, N., Pidoux, E., Cohen, R., Jullienne, A., & Lausson, S. (2004) · Endocrinology · doi:10.1210/en.2003-0915 · Cited by 50
Yoshimoto, T., Takahashi, Y., Kinoshita, T., Sakashita, T., Inoue, H., & Tanabe, T. (2002) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-0193-0_62 · Cited by 35
Rofecoxib does not compromise platelet aggregation during anesthesia and surgery
Silverman, D. G., Halaszynski, T. M., Sinatra, R. S., Luther, M. A., & Binder, C. S. (2003) · Canadian Journal of Anesthesia/Journal canadien d anesthésie · doi:10.1007/bf03018363 · Cited by 31
Cyclo-oxygenase 2 inhibitors: emerging roles in the gut
Grover, J. K., Yadav, S., Vats, V., & Joshi, Y. (2003) · International Journal of Colorectal Disease · doi:10.1007/s00384-002-0443-2 · Cited by 25
Inhibition of cell transformation by sulindac sulfide is confined to specific oncogenic pathways
Gala, M. K., Sun, R., & Yang, V. W. (2002) · Cancer Letters · doi:10.1016/s0304-3835(01)00716-9 · Cited by 21
Colorectal Cancer among Users of Aspirin and Non-Steroidal Antiinflammatory Drugs
Chambers, S., Evans, L. E., & Krishnan, A. (2001) · Epidemiology · doi:10.1097/00001648-200107000-00020 · Cited by 7
Cited by
The lung microenvironment: an important regulator of tumour growth and metastasis
Altorki, N. K., Markowitz, G. J., Gao, D., Port, J. L., Saxena, A., Stiles, B., McGraw, T., & Mittal, V. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-018-0081-9 · Cited by 1,150
Algra, A. M., & Rothwell, P. M. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70112-2 · Cited by 831
The role of COX‐2 in intestinal inflammation and colorectal cancer
Wang, D., & DuBois, R. N. (2010) · Oncogene · doi:10.1038/onc.2009.421 · Cited by 805
Self-citationEngineering CAR-T Cells for Next-Generation Cancer Therapy
Hong, M., Clubb, J. D., & Chen, Y. Y. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.07.005 · Cited by 639
Epidemiology of Glioblastoma Multiforme–Literature Review
Grochans, S., Cybulska, A. M., Simińska, D., Korbecki, J., Kojder, K., Chlubek, D., & Baranowska-Bosiacka, I. (2022) · Cancers · doi:10.3390/cancers14102412 · Cited by 630
Metadata
- Authors
- Wang, D.
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2006-01-01
- Volume
- 55
- Issue
- 1
- Pages
- 115-122
- ISSN
- 0017-5749 (ISSN-L)
- OpenAlex
- W2101249156
- Cited by
- 899
- References
- 114
- FWCI
- 28.11
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.